Skip to content

Opening book details…

About this Medicine article

LBA-08 Results of a phase 1b study of the selective BRAF V600 inhibitor encorafenib in combination with cetuximab alone or cetuximab + alpelisib for treatment of patients with advanced BRAF-mutant metastatic colorectal cancer by Elez, E.; Schellens, J.; van Geel, R.; Bendell, J.; Spreafico, A.; Schuler, M.; Yoshino, T.; Delord, J.-P.; Yamada, Y.; Lolkema, M.; Faris, J. E.; Eskens, F.; Sharma, S.; Yaeger, R.; Lenz, H.-J.; Wainberg, Z.; Avsar, E.; Chatterjee, A.; Jaeger, S.; Demuth, T.; Tabernero, J. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Elez, E.; Schellens, J.; van Geel, R.; Bendell, J.; Spreafico, A.; Schuler, M.; Yoshino, T.; Delord, J.-P.; Yamada, Y.; Lolkema, M.; Faris, J. E.; Eskens, F.; Sharma, S.; Yaeger, R.; Lenz, H.-J.; Wainberg, Z.; Avsar, E.; Chatterjee, A.; Jaeger, S.; Demuth, T.; Tabernero, J.
Publisher
Oxford University Press; Elsevier BV (ISSN 0923-7534)
Published
2015
Field
Medicine (Health Sciences)

More by Elez, E.; Schellens, J.; van Geel, R.; Bendell, J.; Spreafico, A.; Schuler, M.; Yoshino, T.; Delord, J.-P.; Yamada, Y.; Lolkema, M.; Faris, J. E.; Eskens, F.; Sharma, S.; Yaeger, R.; Lenz, H.-J.; Wainberg, Z.; Avsar, E.; Chatterjee, A.; Jaeger, S.; Demuth, T.; Tabernero, J.

Browse all works by Elez, E.; Schellens, J.; van Geel, R.; Bendell, J.; Spreafico, A.; Schuler, M.; Yoshino, T.; Delord, J.-P.; Yamada, Y.; Lolkema, M.; Faris, J. E.; Eskens, F.; Sharma, S.; Yaeger, R.; Lenz, H.-J.; Wainberg, Z.; Avsar, E.; Chatterjee, A.; Jaeger, S.; Demuth, T.; Tabernero, J.